Towards Healthcare Research & Consulting
AI in Cardiology Market
Updated Date: 21 April 2026   |   Report Code: 5077
[email protected] +1 804-441-9344
Download Sample Order Now

AI in Cardiology Market Trends, Advances & Deep Learning in Echocardiography

Forecasts suggest that the AI in cardiology market will expand from USD 1.91 billion in 2024 to USD 36.64 billion by 2034, with a CAGR of 34.38% during this period. AI in cardiology refers to the use of artificial intelligence to analyze heart-related data, assist in diagnosing conditions, predict risks, and improve treatments. It helps doctors detect heart diseases early, interpret ECGs and imaging, and personalize patient care, making heart healthcare faster, more accurate, and efficient.

Last Updated : 21 April 2026 Category: Healthcare IT Insight Code: 5077 Format: PDF / PPT / Excel

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global AI in Cardiology Market Assessment

  • Overview
  • Global AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
    • Hardware
    • Software
    • Services
  • Global AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Cardiac Arrhythmias
    • Stroke
    • Ischemic Heart Disease/CAD
    • Others
  • Global AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East & Africa (MEA)

North America AI in Cardiology Market Assessment

  • Overview
  • North America AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
    • Hardware
    • Software
    • Services
  • North America AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Cardiac Arrhythmias
    • Stroke
    • Ischemic Heart Disease/CAD
    • Others

Europe AI in Cardiology Market Assessment

  • Overview
  • Europe AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
    • Hardware
    • Software
    • Services
  • Europe AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Cardiac Arrhythmias
    • Stroke
    • Ischemic Heart Disease/CAD
    • Others

Asia-Pacific AI in Cardiology Market Assessment

  • Overview
  • Asia-Pacific AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
    • Hardware
    • Software
    • Services
  • Asia-Pacific AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Cardiac Arrhythmias
    • Stroke
    • Ischemic Heart Disease/CAD
    • Others

Latin America AI in Cardiology Market Assessment

  • Overview
  • Latin America  AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
    • Hardware
    • Software
    • Services
  • Latin America AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Cardiac Arrhythmias
    • Stroke
    • Ischemic Heart Disease/CAD
    • Others

Middle East & Africa (MEA) AI in Cardiology Market Assessment

  • Overview
  • Middle East & Africa (MEA) AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
    • Hardware
    • Software
    • Services
  • Middle East & Africa (MEA) AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Cardiac Arrhythmias
    • Stroke
    • Ischemic Heart Disease/CAD
    • Others

Company Profiles

  • Philips
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Siemens Healthineers
  • Medtronic Johnson & Johnson
  • Google Health
  • Microsoft Healthcare
  • Ultromics Limited
  • CardiAl I
  • IBM Watson Health
  • IDOVEN

Conclusion & Recommendations

FAQ's

Answer : The rising prevalence of cardiovascular diseases, including CAD, IHD, and strokes, has indeed led to an increased demand for AI detection methods in cardiology, driving market growth. AI technologies offer promising advancements in early diagnosis and personalized treatment planning for cardiovascular conditions. Continuous advancements in machine learning algorithms, data analytics, and imaging technologies contribute to more accurate and efficient cardiovascular disease detection and management. This innovation-driven progress enhances the overall effectiveness of AI applications in cardiology.

Answer : The North America dominate globally is expected to see a 41 percent increase in heart disease related medical costs between 2010 and 2040, from USD 126.2 billion to USD 177.5 billion. Some of the factors driving this upward trend include the regions expanding number of new artificial intelligence product approvals by regulators, a strong healthcare system and the rapid adoption of cutting edge products.

Answer : World Health Organisation, Food and Drug Administration, National Institute of Health, European Parliamentary Research Service, American College of Cardiology Foundation, British Heart Foundation, Center for Disease Control and Prevension.
Any Questions

Meet the Team

Rohan Patil is a seasoned market research professional with over 5+ years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

Learn more about Rohan Patil

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar